Please enable JavaScript to continue using this application.

Compare $SRRK vs $TNGX | Chartloom

Compare

$SRRK vs $TNGX

Scholar Rock Holding Corp · Tango Therapeutics Inc

SRRK

Scholar Rock Holding Corp

TNGX

Tango Therapeutics Inc

Compare $SRRK vs $TNGX

Comparing Scholar Rock Holding Corp and Tango Therapeutics Inc

SRRKScholar Rock Holding Corp

TNGXTango Therapeutics Inc

SRRKScholar Rock Holding Corp

Market cap

$5.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

122.55x

Rev growth (TTM)

—

YTD performance

-1.4%

52W performance

9.0%

FCF yield

-5.9%

TNGXTango Therapeutics Inc

Market cap

$3.87B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

121.5%

YTD performance

166.6%

52W performance

244.6%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SRRK

TNGX

Detailed metrics comparison

SRRK

Scholar Rock Holding Corp

TNGX

Tango Therapeutics Inc

Market Cap

SRRK$5.06B

TNGX$3.87B

Enterprise Value

SRRK$4.81B

TNGX$3.52B

Price

SRRK$42.19

TNGX$23.81

P/E Ratio

SRRKN/A

TNGXN/A

P/S Ratio

SRRK120.52x

TNGX71.83x

EV/Sales

SRRK115.43x

TNGX65.41x

EV/EBITDA

SRRK0.00x

TNGX0.00x

P/B Ratio

SRRK22.46x

TNGX3.82x

P/FCF Ratio

SRRKN/A

TNGXN/A

EV/FCF

SRRK-16.21x

TNGX-24.40x

PEG Ratio

SRRKN/A

TNGXN/A

Forward P/E (NTM)

SRRKN/A

TNGXN/A

Forward P/S (NTM)

SRRK122.55x

TNGXN/A

Revenue (TTM)

SRRK$0

TNGX$54M

Revenue Growth (YoY)

SRRKN/A

TNGX121.5%

Forward Rev Growth

SRRK2628.0%

TNGX732.8%

Gross Margin (TTM)

SRRK0.0%

TNGX0.0%

Operating Margin (TTM)

SRRK0.0%

TNGX0.0%

EBITDA Margin (TTM)

SRRK0.0%

TNGX-249.8%

Net Margin (TTM)

SRRK0.0%

TNGX-229.9%

FCF Margin (TTM)

SRRKN/A

TNGX-268.1%

Net Income (TTM)

SRRK$-406M

TNGX$-124M

FCF (TTM)

SRRK$-297M

TNGX$-144M

EPS (TTM)

SRRK-$3.11

TNGX-$0.83

ROE (TTM)

SRRK-15912.0%

TNGX-2574.0%

ROA (TTM)

SRRK-8660.0%

TNGX-2336.0%

ROIC (TTM)

SRRK-10069.0%

TNGX-2574.0%

Cash

SRRK$437M

TNGX$346M

Debt

SRRK$196M

TNGX$0

Net Cash/Debt

SRRK$241M

TNGX$346M

Current Ratio (TTM)

SRRK7.02x

TNGX50.82x

Quick Ratio (TTM)

SRRK6.84x

TNGX49.95x

Debt/Equity (TTM)

SRRK0.77x

TNGX0.00x

Debt/Assets (TTM)

SRRK0.0%

TNGX0.0%

Interest Coverage (TTM)

SRRKN/A

TNGXN/A

Net Debt/EBITDA (TTM)

SRRK0.00x

TNGX0.00x

Beta

SRRK0.76

TNGX1.18

52W Performance

SRRK9.0%

TNGX244.6%

YTD Performance

SRRK-1.4%

TNGX166.6%

% from 52W High

SRRK-31.7%

TNGX-30.8%

% from 52W Low

SRRK55.9%

TNGX255.9%

Asset Turnover (TTM)

SRRK0.16x

TNGX0.26x

FCF Yield (TTM)

SRRK-5.9%

TNGX-3.7%

Earnings Yield (TTM)

SRRK-8.0%

TNGX-3.2%

Dividend Yield (TTM)

SRRKN/A

TNGXN/A

Rule of 40

SRRK0.0

TNGX-146.6

EV/GP/RG

SRRKN/A

TNGXN/A

Ticker research

View SRRK research View TNGX research

Metric	SRRK Scholar Rock Holding Corp	TNGX Tango Therapeutics Inc
Market & Valuation
Market Cap	$5.06B	$3.87B
Enterprise Value	$4.81B	$3.52B
Price	$42.19	$23.81
P/E Ratio	N/A	N/A
P/S Ratio	120.52x	71.83x
EV/Sales	115.43x	65.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	22.46x	3.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.21x	-24.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	122.55x	N/A
Revenue & Growth
Revenue (TTM)	$0	$54M
Revenue Growth (YoY)	N/A	121.5%
Forward Rev Growth	2628.0%	732.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-249.8%
Net Margin (TTM)	0.0%	-229.9%
FCF Margin (TTM)	N/A	-268.1%
Net Income (TTM)	$-406M	$-124M
FCF (TTM)	$-297M	$-144M
EPS (TTM)	-$3.11	-$0.83
ROE (TTM)	-15912.0%	-2574.0%
ROA (TTM)	-8660.0%	-2336.0%
ROIC (TTM)	-10069.0%	-2574.0%
Financial Health
Cash	$437M	$346M
Debt	$196M	$0
Net Cash/Debt	$241M	$346M
Current Ratio (TTM)	7.02x	50.82x
Quick Ratio (TTM)	6.84x	49.95x
Debt/Equity (TTM)	0.77x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	1.18
52W Performance	9.0%	244.6%
YTD Performance	-1.4%	166.6%
% from 52W High	-31.7%	-30.8%
% from 52W Low	55.9%	255.9%
Efficiency & Yields
Asset Turnover (TTM)	0.16x	0.26x
FCF Yield (TTM)	-5.9%	-3.7%
Earnings Yield (TTM)	-8.0%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-146.6
EV/GP/RG	N/A	N/A
Ticker research	View SRRK research	View TNGX research

Valuation

P/S Ratio

TNGX

71.83x

SRRK

120.52x

EV/FCF

TNGX

-24.40x

SRRK

-16.21x

Growth & revenue

Revenue Growth TTM

TNGX

121.5%

Forward Revenue Growth

SRRK

2628.0%

TNGX

732.8%

Profitability & performance

Gross Margin

SRRK

0.0%

TNGX

0.0%

ROE

TNGX

-2574.0%

SRRK

-15912.0%

FCF Yield %

TNGX

-3.7%

SRRK

-5.9%

52-Week Performance

TNGX

244.6%

SRRK

9.0%

Detailed metrics comparison

SRRK

Scholar Rock Holding Corp

TNGX

Tango Therapeutics Inc

Market Cap

SRRK$5.06B

TNGX$3.87B

Enterprise Value

SRRK$4.81B

TNGX$3.52B

Price

SRRK$42.19

TNGX$23.81

P/E Ratio

SRRKN/A

TNGXN/A

P/S Ratio

SRRK120.52x

TNGX71.83x

EV/Sales

SRRK115.43x

TNGX65.41x

EV/EBITDA

SRRK0.00x

TNGX0.00x

P/B Ratio

SRRK22.46x

TNGX3.82x

P/FCF Ratio

SRRKN/A

TNGXN/A

EV/FCF

SRRK-16.21x

TNGX-24.40x

PEG Ratio

SRRKN/A

TNGXN/A

Forward P/E (NTM)

SRRKN/A

TNGXN/A

Forward P/S (NTM)

SRRK122.55x

TNGXN/A

Revenue (TTM)

SRRK$0

TNGX$54M

Revenue Growth (YoY)

SRRKN/A

TNGX121.5%

Forward Rev Growth

SRRK2628.0%

TNGX732.8%

Gross Margin (TTM)

SRRK0.0%

TNGX0.0%

Operating Margin (TTM)

SRRK0.0%

TNGX0.0%

EBITDA Margin (TTM)

SRRK0.0%

TNGX-249.8%

Net Margin (TTM)

SRRK0.0%

TNGX-229.9%

FCF Margin (TTM)

SRRKN/A

TNGX-268.1%

Net Income (TTM)

SRRK$-406M

TNGX$-124M

FCF (TTM)

SRRK$-297M

TNGX$-144M

EPS (TTM)

SRRK-$3.11

TNGX-$0.83

ROE (TTM)

SRRK-15912.0%

TNGX-2574.0%

ROA (TTM)

SRRK-8660.0%

TNGX-2336.0%

ROIC (TTM)

SRRK-10069.0%

TNGX-2574.0%

Cash

SRRK$437M

TNGX$346M

Debt

SRRK$196M

TNGX$0

Net Cash/Debt

SRRK$241M

TNGX$346M

Current Ratio (TTM)

SRRK7.02x

TNGX50.82x

Quick Ratio (TTM)

SRRK6.84x

TNGX49.95x

Debt/Equity (TTM)

SRRK0.77x

TNGX0.00x

Debt/Assets (TTM)

SRRK0.0%

TNGX0.0%

Interest Coverage (TTM)

SRRKN/A

TNGXN/A

Net Debt/EBITDA (TTM)

SRRK0.00x

TNGX0.00x

Beta

SRRK0.76

TNGX1.18

52W Performance

SRRK9.0%

TNGX244.6%

YTD Performance

SRRK-1.4%

TNGX166.6%

% from 52W High

SRRK-31.7%

TNGX-30.8%

% from 52W Low

SRRK55.9%

TNGX255.9%

Asset Turnover (TTM)

SRRK0.16x

TNGX0.26x

FCF Yield (TTM)

SRRK-5.9%

TNGX-3.7%

Earnings Yield (TTM)

SRRK-8.0%

TNGX-3.2%

Dividend Yield (TTM)

SRRKN/A

TNGXN/A

Rule of 40

SRRK0.0

TNGX-146.6

EV/GP/RG

SRRKN/A

TNGXN/A

Ticker research

View SRRK research View TNGX research

Metric	SRRK Scholar Rock Holding Corp	TNGX Tango Therapeutics Inc
Market & Valuation
Market Cap	$5.06B	$3.87B
Enterprise Value	$4.81B	$3.52B
Price	$42.19	$23.81
P/E Ratio	N/A	N/A
P/S Ratio	120.52x	71.83x
EV/Sales	115.43x	65.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	22.46x	3.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.21x	-24.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	122.55x	N/A
Revenue & Growth
Revenue (TTM)	$0	$54M
Revenue Growth (YoY)	N/A	121.5%
Forward Rev Growth	2628.0%	732.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-249.8%
Net Margin (TTM)	0.0%	-229.9%
FCF Margin (TTM)	N/A	-268.1%
Net Income (TTM)	$-406M	$-124M
FCF (TTM)	$-297M	$-144M
EPS (TTM)	-$3.11	-$0.83
ROE (TTM)	-15912.0%	-2574.0%
ROA (TTM)	-8660.0%	-2336.0%
ROIC (TTM)	-10069.0%	-2574.0%
Financial Health
Cash	$437M	$346M
Debt	$196M	$0
Net Cash/Debt	$241M	$346M
Current Ratio (TTM)	7.02x	50.82x
Quick Ratio (TTM)	6.84x	49.95x
Debt/Equity (TTM)	0.77x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	1.18
52W Performance	9.0%	244.6%
YTD Performance	-1.4%	166.6%
% from 52W High	-31.7%	-30.8%
% from 52W Low	55.9%	255.9%
Efficiency & Yields
Asset Turnover (TTM)	0.16x	0.26x
FCF Yield (TTM)	-5.9%	-3.7%
Earnings Yield (TTM)	-8.0%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-146.6
EV/GP/RG	N/A	N/A
Ticker research	View SRRK research	View TNGX research